Imaging Biomarkers Market - Emerging Trends and New Technologies Research 2015 - 2023
Obtain Report Details @ http://www.transparencymarketresearch.com/imaging-biomarkers-market.html
Therefore, biomarkers are more useful to detect and monitor responses of the body to a disease or condition. Since cancer is associated with alterations in the status and expression of multiple genes, technologies are under development that could provide important insights into the etiology of the cancer and be vital to detect, diagnose, and treat cancer. Biomarkers, help in early detection of cancer, resulting in increased survival rate among cancer patients.
The global imaging biomarkers market is segmented on the basis of imaging technologies, applications and geography. Imaging technologies include positron emission tomography (PET), ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and single-photon emission computed tomography (SPECT). Personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis and forensic applications are the major application segments for imaging biomarkers. Determination of disease mechanisms, toxicity profiling, and in target discovery and validation are some of the key drivers propelling the demand for imaging biomarkers.
MRI procedures use magnetic field and are thus safer than other imaging techniques such as CT and PET scan. Multi parametric MRI is emerging as an improved technique and best imaging modality for localizing and staging of various cancers. PET scanners due to their high cost, have their usage limited to large hospitals. These are useful in cancer staging and to determine the preseance of metastasis. It is estimated that approximately 95% of all PET procedures performed are related to cancers and is the normal standard of care in the diagnosis, staging and determining treatment of cancer patients.
Technologically advanced imaging modalities such as PET/MR, provide new tools for biomarker imaging by combining morphological and molecular imaging. Present day CT equipment produce 3D images by capturing pictures in a helical (or spiral) way and the most recent equipment have the ability to take more images in a very short time. In certain cases, contrast medium dyes are used during imaging for clear visualization of tissues. Ultrasound imaging has gained popularity along with mammogram for detecting breast cancer, as it is non-invasive, cost effective, and is widely available.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2381
Geographically, the global imaging biomarkers market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. North America comprising of the U.S. and Canada dominates the global imaging biomarkers market followed by the European countries due to well established healthcare infrastructure in these regions. Emerging economies in the Asia Pacific region are expected to be the fastest growing region in the near future due to rising awareness regarding the imaging biomarkers and continuous improvement in the healthcare infrastructure.
Various organizations have been formed in order to assist in biomarkers discovery and their assessment in drug development and response to therapy. These organizations include The Biomarkers Consortium, International Cancer Biomarker Consortium and The Predictive Safety Testing Consortium. Abbott Laboratories, Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, Affymetrix Inc., Danaher Corporation, Qiagen NV, DiagnoCure, Inc., Gen-Probe Inc., F. Hoffmann La Roche Ltd., and Siemens Healthcare.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imaging Biomarkers Market - Emerging Trends and New Technologies Research 2015 - 2023 here
News-ID: 545709 • Views: 225
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for Biomarker
Global Genomic Biomarker Market Research and Forecast 2018-2023
Global genomic biomarkers market size, share, market intelligence, market trends, research and analysis report by disease indication (oncology, cardiology, neurology) by end users (hospitals, diagnostic and research laboratories) forecast 2018-2023 According to the OMR analysis, the global genomic biomarker market is growing at a moderate rate during 2018-2023. The global genomic biomarker market has witnessed a moderate growth due to increasing cases of chronic diseases and rising healthcare expenditure. The global
Key Findings of the Global Biomarker Market
A new business intelligence report released by HTF MI with title “Global Biomarker Market Size, Status and Forecast 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: https://www.htfmarketreport.com/sample-report/1222502-global-biomarker-market-1 If
Global Cancer Biomarker Market Strategies and Forecast 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. QYResearchReports.com has added a new report covering the global Cancer Biomarker market to its vast database. The research report studies the global Cancer Biomarker market to analyze the factors impacting it. The report has been divided into several chapters that discuss the global Cancer Biomarker market in absolute detail. The
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising